GMED.NYSEGlobus Medical INC

Form 4: Globus Medical CEO Daniel Scavilla Executes Stock Options and Sells Shares

Sentiment:

SEC Form 4 Filing

📋All filings for Globus Medical INC
🔒Login to Follow

Globus Medical's CEO, Daniel Scavilla, exercised stock options and sold 60,000 shares of Class A Common Stock on November 6, 2024, according to a recent SEC filing.

Summary

  • Daniel T Scavilla, the President and CEO of Globus Medical Inc, executed stock options to acquire 60,000 shares of Class A Common Stock on November 6, 2024.
  • The options were exercised at prices of $26.27 and $43.77 per share, resulting in the acquisition of 30,000 shares at each price point.
  • Simultaneously, Scavilla sold 60,000 shares of Class A Common Stock at a price of $80.02 per share.
  • The sale was conducted under a pre-arranged Rule 10b5-1 trading plan established on June 7, 2024.
  • Following these transactions, Scavilla directly owns 0 shares of Class A Common Stock and 50,000 stock options.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions appear to be part of a pre-planned strategy. The CEO is exercising options and selling shares, which is a common practice.

Industry Context

Insider transactions are common, and the use of a pre-arranged Rule 10b5-1 trading plan suggests the sale was planned and not based on any immediate inside information.

Stakeholder Impact

  • The sale of shares by the CEO could have a minor impact on shareholder sentiment, but the pre-planned nature of the sale mitigates potential concerns.

Key Dates

DateDescription
January 30, 2017Date when 30,000 stock options were granted, exercisable until January 30, 2027.
January 22, 2018Date when 30,000 stock options were granted, exercisable until January 22, 2028.
June 7, 2024Date of the Rule 10b5-1 trading plan.
November 6, 2024Date of the stock option exercise and sale of shares.
November 8, 2024Date of the SEC filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.